Mira Pharmaceuticals reported total assets of $11.09M and total liabilities of $0.69M for the quarter ended Dec 2025, up 279.5% year over year. This balance sheet covers 15 quarters of results from Jun 2022 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.83M | 0.19M | 0.35M | 0.00M | 0.02M | 5.87M | 4.60M | 3.53M | 4.14M | 2.83M | 1.21M | 0.73M | 2.64M | 6.35M | |
| Short-term InvestmentsInvestments (Current) | 4.89M | 4.68M | |||||||||||||
| Cash & Current Investments | 0.83M | 0.19M | 0.35M | 0.00M | 0.02M | 5.87M | 4.60M | 3.53M | 4.14M | 2.83M | 1.21M | 0.73M | 7.54M | 11.03M | |
| Receivables - NetNet Receivables | 0.01M | 0.01M | |||||||||||||
| Receivables - OtherOther Receivables | 0.05M | 0.05M | 0.01M | 0.18M | 0.08M | 0.04M | 0.04M | 0.08M | 0.08M | 0.08M | 0.04M | ||||
| Receivables | 0.02M | 0.04M | |||||||||||||
| Prepaid Assets | 0.04M | 0.25M | 0.24M | 0.19M | 0.09M | 0.05M | 0.16M | 0.10M | 0.06M | 0.03M | |||||
| Current Assets | 0.49M | 0.42M | 6.07M | 4.86M | 3.71M | 4.23M | 2.89M | 1.36M | 0.83M | 7.60M | 11.06M | ||||
| Non-Current Assets | |||||||||||||||
| Other Non-Current Assets | 3.50M | 3.50M | 3.50M | ||||||||||||
| Non-Current Assets | 0.36M | 3.40M | 2.95M | 0.07M | 0.09M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | ||||
| Assets | 0.86M | 3.83M | 9.02M | 4.93M | 3.81M | 4.27M | 2.92M | 1.40M | 0.87M | 7.63M | 11.09M | ||||
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payables | 0.81M | 0.66M | 0.78M | 0.54M | 0.64M | 0.69M | 0.72M | 0.10M | 0.30M | 0.08M | 0.13M | ||||
| Payables | 0.81M | 0.66M | 0.78M | 0.54M | 0.64M | 0.69M | 0.72M | 0.10M | 0.30M | 0.08M | 0.13M | ||||
| Accumulated Expenses | 0.03M | 0.01M | 0.01M | 0.30M | 0.01M | ||||||||||
| Other Accumulated Expenses | 0.02M | 0.04M | 0.01M | 0.57M | |||||||||||
| Short term Debt | 0.13M | 1.80M | |||||||||||||
| Total Current Liabilities | 1.37M | 2.58M | 0.87M | 0.56M | 0.65M | 0.69M | 0.72M | 0.11M | 0.30M | 0.08M | 0.70M | ||||
| Non-Current Liabilities | |||||||||||||||
| Operating Leases | 0.08M | 0.05M | 0.03M | ||||||||||||
| Other Non-Current Liabilities | 0.10M | ||||||||||||||
| Total Non-Current Liabilities | 1.35M | 0.56M | |||||||||||||
| Total Liabilities | 1.45M | 2.63M | 0.90M | 0.56M | 0.65M | 0.69M | 0.72M | 0.11M | 0.30M | 0.08M | 0.69M | ||||
| Shareholder's Equity | |||||||||||||||
| Total Debt | 0.13M | 1.80M | |||||||||||||
| Common Equity | 1.08M | 0.32M | -0.60M | -1.79M | 1.20M | 8.12M | 4.37M | 3.16M | 2.22M | 3.57M | 2.20M | 1.29M | 0.57M | 7.55M | 10.40M |
| Liabilities and Shareholders Equity | 0.86M | 3.83M | 9.02M | 4.93M | 3.81M | 4.27M | 2.92M | 1.40M | 0.87M | 7.63M | 11.09M | ||||
| Retained Earnings | -9.30M | -11.91M | -15.50M | -21.29M | -23.00M | -26.74M | -29.14M | -30.92M | -32.46M | -33.60M | -39.58M |
Pull Mira Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=MIRA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "MIRA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=MIRA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();